BIOMAT Database Logo BIOMAT Database Logo

The clinical use of class IC antiarrhythmic drugs. 1989

F Abi Samra

Flecainide, encainide, and propafenone belong to class IC antiarrhythmic drugs. They are new and potent drugs which markedly depress Phase 0 of the action potential without affecting repolarization. Class IC drugs are very potent suppressors of premature ventricular complexes but their efficacy in the treatment of ventricular tachycardia is only comparable to that of class IA agents. Although noncardiac side effects are minimal, myocardial depression and serious proarrhythmic effects are not infrequently noted. A thorough understanding of the pharmacodynamics and toxicity potential of these drugs is therefore essential for their safe usage.

UI MeSH Term Description Entries
D011405 Propafenone An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. Apo-Propafenone,Arythmol,Baxarytmon,Cuxafenon,Fenoprain,Jutanorm,Nistaken,Norfenon,Pintoform,Prolecofen,Propafenon AL,Propafenon Hexal,Propafenon Minden,Propafenone Hydrochloride,Propafenone Hydrochloride, (R)-Isomer,Propafenone Hydrochloride, (S)-Isomer,Propafenone, (+-)-Isomer,Propafenone, (R)-Isomer,Propafenone, (S)-Isomer,Propamerck,Rythmol,Rytmo-Puren,Rytmogenat,Rytmonorm,SA-79,Hydrochloride, Propafenone,SA 79,SA79
D005424 Flecainide A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS. Flecainide Acetate,Apocard,Flecadura,Flecainid-Isis,Flecainide Monoacetate,Flecainide Monoacetate, (+-)-Isomer,Flecainide Monoacetate, (R)-Isomer,Flecainide Monoacetate, (S)-Isomer,Flecainide, (R)-Isomer,Flecainide, (S)-Isomer,Flecainide, 5-HO-N-(6-oxo)-Derivative,Flecainide, 5-HO-N-(6-oxo)-Derivative, (+-)-Isomer,Flecatab,Flécaïne,R818,Tambocor,Flecainid Isis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000813 Anilides Any aromatic amide obtained by acylation of aniline.
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D016700 Encainide One of the ANTI-ARRHYTHMIA AGENTS, it blocks VOLTAGE-GATED SODIUM CHANNELS and slows conduction within the His-Purkinje system and MYOCARDIUM. Encainide Hydrochloride,Encainide Hydrochloride, (+-)-Isomer,Encainide, (+)-Isomer,Encainide, (-)-Isomer,Enkaid,MJ-9067,MJ 9067,MJ9067

Related Publications

F Abi Samra
[Class Ic antiarrhythmic drugs--flecainide and propafenone].
July 1990, Harefuah,
F Abi Samra
Ic antiarrhythmic drugs.
October 1989, Journal of clinical pharmacology,
F Abi Samra
[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia].
February 1991, Bulletin de l'Academie nationale de medecine,
F Abi Samra
Clinical course and outcome in class IC antiarrhythmic overdose.
January 1990, Journal of toxicology. Clinical toxicology,
F Abi Samra
Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
February 2018, Heart rhythm,
F Abi Samra
Use of class IC antiarrhythmic drugs in patients with structural heart disease and implantable cardioverter defibrillator.
February 2024, Clinical research in cardiology : official journal of the German Cardiac Society,
F Abi Samra
Reverse use dependence of antiarrhythmic class Ia, Ib, and Ic: effects of drugs on the action potential duration?
November 1992, Pacing and clinical electrophysiology : PACE,
F Abi Samra
Propafenone shows class Ic and class II antiarrhythmic effects.
April 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
F Abi Samra
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ.
June 1991, Naunyn-Schmiedeberg's archives of pharmacology,
F Abi Samra
Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.
January 2001, Journal of electrocardiology,
Copied contents to your clipboard!